{"id":"W4408531295","doi":"10.3390/curroncol32030169","title":"Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; Servier; Seagen; Clovis Oncology; Eisai; Jazz Pharmaceuticals; National Cancer Institute; Baxalta; F. Hoffmann-La Roche; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Daiichi Sankyo Europe; Bayer HealthCare; Sanofi; Pfizer; Myriad Genetics; Eli Lilly and Company; AstraZeneca; Queen Mary University of London","keywords":"Medicine; Breast cancer; Internal medicine; Metastatic breast cancer; Twist; Cancer; Adverse effect; Oncology; Chemotherapy; Randomization; Population; Quality of life (healthcare); Clinical trial; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001247649,0.0002719003,0.001222119,0.0007689059,0.00003071925,0.000005777109,0.0001474578,0.0000772339,0.0003858884],"category_scores_gemma":[0.00002168952,0.0002096294,0.0001533173,0.002318586,0.0002507523,0.00007497844,0.00002944123,0.0002432043,0.000002002823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001285433,"about_ca_system_score_gemma":0.0005126355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004827366,"about_ca_topic_score_gemma":0.001636788,"domain_scores_codex":[0.9983054,0.000116573,0.000527078,0.0004365253,0.0002372254,0.000377219],"domain_scores_gemma":[0.9987917,0.00009892364,0.0003017859,0.0003865992,0.0003222582,0.00009873979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003979174,0.001574464,0.6928317,0.0001956359,0.001988556,0.000006237261,0.0005130377,0.0001662656,0.00007881559,0.00005968297,0.00006590696,0.2985405],"study_design_scores_gemma":[0.0121974,0.0006529101,0.9719829,0.0004143191,0.002615191,0.000004717856,0.0001131049,0.0003864038,0.0001968121,0.0000475948,0.01120783,0.0001808203],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944617,0.002120001,0.0007354539,0.001028009,0.0001980775,0.0009342127,0.000197397,0.00004660886,0.0002785047],"genre_scores_gemma":[0.9984233,0.0003127265,0.000323152,0.0003366603,0.00002829843,0.0002435037,0.0001612716,0.00002680112,0.0001442254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2983597,"threshold_uncertainty_score":0.8548437,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02874331636762249,"score_gpt":0.3872256807176728,"score_spread":0.3584823643500503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}